The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: sandostatin     Quarter: 2016Q3

Total Records: 2,045     Number of Pages: 103

DRUGNAME PT EventCount
SANDOSTATIN LAR DEPOT Blood electrolytes decreased 2
SANDOSTATIN LAR DEPOT Blood sodium decreased 2
SANDOSTATIN LAR DEPOT Bone neoplasm 2
SANDOSTATIN LAR DEPOT Breast calcifications 2
SANDOSTATIN LAR DEPOT Breast enlargement 2
SANDOSTATIN LAR DEPOT Calculus urinary 2
SANDOSTATIN LAR DEPOT Carcinoid heart disease 2
SANDOSTATIN LAR DEPOT Cardiac murmur 2
SANDOSTATIN LAR DEPOT Cardio-respiratory arrest 2
SANDOSTATIN LAR DEPOT Central nervous system lesion 2
SANDOSTATIN LAR DEPOT Cerebrospinal fluid leakage 2
SANDOSTATIN LAR DEPOT Chronic kidney disease 2
SANDOSTATIN LAR DEPOT Cognitive disorder 2
SANDOSTATIN LAR DEPOT Coronary artery occlusion 2
SANDOSTATIN LAR DEPOT Dermatitis 2
SANDOSTATIN LAR DEPOT Device failure 2
SANDOSTATIN LAR DEPOT Disease progression 2
SANDOSTATIN LAR DEPOT Dry eye 2
SANDOSTATIN LAR DEPOT Dysgraphia 2
SANDOSTATIN LAR DEPOT Dyslipidaemia 2

Total Records: 2,045     Number of Pages: 103